The reality of an intermediate type between asthma and COPD in practice

Respiratory Care

Volumn 57, Issue 8, 2012, Pages 1248-1253

  Kim, Tae Bum ^a   Oh, Yeon Mok ^a   Chang, Yoon Seok ^b   Cho, You Sook ^a   Jang, An Soo ^c   Cho, Sang Heon ^b   Choi, Byoung Whui ^d   Lee, Sang Do ^a   Moon, Hee Bom ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Soonchunhyang University   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

Asthma; COPD

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASTHMA; ATOPY; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DISEASE CLASSIFICATION; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ADMISSION; HUMAN; INTERMEDIATE TYPE CHRONIC OBSTRUCTIVE LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; RETROSPECTIVE STUDY; SEX; SMOKING; SOUTH KOREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; ASTHMA; BODY MASS INDEX; BRONCHODILATOR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING;

EID: 84864797336     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01232     Document Type: Article

References (19)

1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31(1):143-178.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.
3. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8(3):183-192.
4. Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008;31(4):742-750.
5. Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008;134(1):14-19.
6. Kim TB, Park CS, Bae YJ, Cho YS, Moon HB. Factors associated with severity and exacerbation of asthma: a baseline analysis of the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA). Ann Allergy Asthma Immunol 2009;103(4):311-317.
7. Lee YK, Oh YM, Lee JH, Kim EK, Kim N, Seo JB, et al. Quantitative Assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008;186(3):157-165.
8. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152(3):1107-1136.
9. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.
10. Kim TB, Kim YK, Chang YS, Kim SH, Hong SC, Jee YK, et al. Association between sensitization to outdoor spider mites and clinical manifestations of asthma and rhinitis in the general population of adults. J Korean Med Sci 2006;21(2):247-252.
11. Kim YK, Lee MH, Jee YK, Hong SC, Bae JM, Chang YS, et al. Spider mite allergy in apple-cultivating farmers: European red mite (Panonychus ulmi) and two-spotted spider mite (Tetranychus urticae) may be important allergens in the development of work-related asthma and rhinitis symptoms. J Allergy Clin Immunol 1999;104(6):1285-1292.
12. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126(1):59-65.
13. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339(17):1194-1200.
14. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004;126(2 Suppl):117S-124S; discussion 159S-161S.
15. Gross NJ, Co E, Skorodin MS. Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects. Chest 1989;96(5):984-987.
16. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58(8):659-664.
17. Kesten S, Rebuck AS. Is the short-term response to inhaled betaadrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest 1994;105(4):1042-1045.
18. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160(11):1683-1689.
19. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med 2008;102(1):50-5